Open AccessPosted Content
Methods for the Economic Evaluation of Health Care Programmes
Reads0
Chats0
TLDR
The fourth edition of the Methods for the Economic Evaluation of Health Care Programmes as mentioned in this paper has been thoroughly revised and updated, making it essential reading for anyone commissioning, undertaking, or using economic evaluations in health care, including health service professionals, health economists, and health care decision makers.Abstract:
The purpose of economic evaluation is to inform decisions intended to improve healthcare. The new edition of Methods for the Economic Evaluation of Health Care Programmes equips the reader with the necessary tools and understanding required to undertake evaluations by providing an outline of key principles and a 'tool kit' based on the authors' own experiences of undertaking economic evaluations. Building on the strength of the previous edition, the accessible writing style ensures the text is key reading for the non-expert reader, as no prior knowledge of economics is required. The book employs a critical appraisal framework, which is useful both to researchers conducting studies and to decision-makers assessing them. Practical examples are provided throughout to aid learning and understanding. The book discusses the analytical and policy challenges that face health systems in seeking to allocate resources efficiently and fairly. New chapters include 'Principles of economic evaluation' and 'Making decisions in healthcare' which introduces the reader to core issues and questions about resource allocation, and provides an understanding of the fundamental principles which guide decision making. A key part of evidence-based decision making is the analysis of all the relevant evidence to make informed decisions and policy. The new chapter 'Identifying, synthesising and analysing evidence' highlights the importance of systematic review, and how and why these methods are used. As methods of analysis continue to develop, the chapter on 'Characterising, reporting and interpreting uncertainty' introduces the reader to recent methods of analysis and why characterizing uncertainty matters for health care decisions. The fourth edition of Methods for the Economic Evaluation of Health Care Programmes has been thoroughly revised and updated, making it essential reading for anyone commissioning, undertaking, or using economic evaluations in health care, including health service professionals, health economists, and health care decision makers.read more
Citations
More filters
Journal ArticleDOI
Cost Analysis and Cost Determinants in a European Inflammatory Bowel Disease Inception Cohort With 10 Years of Follow-up Evaluation
Selwyn Odes,Hillel Vardi,Michael Friger,Frank Wolters,Maurice G. Russel,Lene Riis,Pia Munkholm,P. Politi,Epameinondas V. Tsianos,Juan Clofent,Severine Vermeire,Estela Monteiro,Iannis Mouzas,Giovanni Fornaciari,Jildou Sijbrandij,Charles Limonard,Gilbert Van Zeijl,Colm O'Morain,Bjørn Moum,Morten H. Vatn,Reinhold W. Stockbrügger +20 more
TL;DR: In this multinational, population-based, time-dependent characterization of the health care cost of inflammatory bowel disease, increased expenditure was driven largely by country, diagnosis, hospitalization, and follow-up year.
Mapt study: a multidomain approach for preventing alzheimer’s disease: design and baseline data
Bruno Vellas,Isabelle Carrié,Sophie Gillette-Guyonnet,Jacques Touchon,Thierry Dantoine,J. F. Dartigues,M.-N. Cuffi,Serge Bordes,Yannick Gasnier,P. Robert,Lawrence Bories,Olivier Rouaud,Françoise Desclaux,Kristelle Sudres,Marc Bonnefoy,Alain Pesce,Carole Dufouil,Stéphane Lehéricy,Marie Chupin,Jean-François Mangin,Pierre Payoux,D. Adel,Philippe Legrand,D Catheline,C Kanony,M. Zaim,Laurent Molinier,Nadège Costa,J. Delrieu,Thierry Voisin,Catherine Faisant,Françoise Lala,Fati Nourhashemi,Yves Rolland,G. Abellan Van Kan,Charlotte Dupuy,Christelle Cantet,P Cestac,Sylvie Belleville,Sherry L. Willis,Matteo Cesari,M. Weiner,Maria Soto,Pierre-Jean Ousset,Sandrine Andrieu +44 more
TL;DR: The MAPT trial is presently the first largest and longest multidomain preventive trial relevant to cognitive decline in older adults with subjective memory complaints and is likely to be easily implemented within the general population.
Journal ArticleDOI
Recombinant human growth hormone for the treatment of growth disorders in children: a systematic review and economic evaluation.
Andrea Takeda,Keith Cooper,A Bird,L Baxter,Geoff K Frampton,Elena Gospodarevskaya,Kathy M. Welch,Jackie Bryant +7 more
TL;DR: The clinical effectiveness and cost-effectiveness of rhGH compared with treatment strategies without rhGH for children with GHD, TS, PWS, CRI, SGA and SHOX-D and those born SGA is assessed.
Journal ArticleDOI
Clinical and educational telepsychiatry applications: a review
TL;DR: Telepsychiatry is feasible, increases access to care, enables specialty consultation, yields positive outcomes, allows reliable evaluation, has few negative aspects in terms of communication, generally satisfies patients and providers, facilitates education, and empowers parties using it.
Journal ArticleDOI
Need for differential discounting of costs and health effects in cost effectiveness analyses.
TL;DR: The decision of the National Institute for Health and Clinical Excellence to abandon differential discounting of future health is a step backwards and could change funding decisions.